The researchers used four major databases to collate relevant studies on the use of nonprescribed weight loss aids by teenagers around the world.
Mosaic Therapeutics appoints Dr Barry Davies as CSO
Dr. Barry Davies joins Mosaic Therapeutics as CSO, bringing 25 years of drug discovery expertise to advance targeted oncology therapies and precision medicine.